Apyx Medical (APYX) Revenue (2011 - 2026)

Apyx Medical (APYX) has reported Revenue for 16 consecutive years, with $13.9 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Revenue rose 22.08% year-over-year to $13.9 million; the trailing twelve-month figure through Jun 2026 stood at $58.4 million (up 25.59% YoY), and the FY2025 full-year result was $52.8 million, up 9.86% from the prior year.
• Revenue advanced to $13.9 million in Q2 2026 per APYX's latest filing, from $12.5 million in the prior quarter.
• Across five years, Revenue topped out at $19.2 million in Q4 2025 and bottomed at $9.1 million in Q3 2022.
• Historically, Revenue has averaged $12.5 million across 5 years, with a median of $12.3 million in 2024.
• The widest YoY moves for Revenue: up 44.63% in 2022, down 25.04% in 2022.
• Over 5 years, Revenue stood at $12.6 million in 2022, then gained by 16.26% to $14.7 million in 2023, then dropped by 3.0% to $14.2 million in 2024, then surged by 34.75% to $19.2 million in 2025, then fell by 27.55% to $13.9 million in 2026.
• According to Business Quant data, Revenue over the past three periods registered $13.9 million, $12.5 million, and $19.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.